13,388 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Diversify Wealth Management LLC

Diversify Wealth Management LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 13,388 shares of the healthcare conglomerate’s stock, valued at approximately $6,818,000. UnitedHealth Group makes up about 0.8% of Diversify Wealth Management LLC’s investment portfolio, making the stock its 26th largest holding.

Several other institutional investors have also recently modified their holdings of UNH. Seven Mile Advisory increased its position in UnitedHealth Group by 5.5% during the second quarter. Seven Mile Advisory now owns 1,726 shares of the healthcare conglomerate’s stock worth $879,000 after buying an additional 90 shares in the last quarter. Vista Capital Partners Inc. increased its position in UnitedHealth Group by 5.3% during the 2nd quarter. Vista Capital Partners Inc. now owns 639 shares of the healthcare conglomerate’s stock worth $325,000 after purchasing an additional 32 shares in the last quarter. Lyell Wealth Management LP lifted its holdings in UnitedHealth Group by 13.0% in the 2nd quarter. Lyell Wealth Management LP now owns 8,556 shares of the healthcare conglomerate’s stock valued at $4,357,000 after purchasing an additional 985 shares in the last quarter. J.W. Cole Advisors Inc. grew its holdings in shares of UnitedHealth Group by 70.3% during the second quarter. J.W. Cole Advisors Inc. now owns 8,893 shares of the healthcare conglomerate’s stock worth $4,529,000 after buying an additional 3,672 shares in the last quarter. Finally, Chronos Wealth Management LLC boosted its position in UnitedHealth Group by 2.5% during the second quarter. Chronos Wealth Management LLC now owns 17,463 shares of the healthcare conglomerate’s stock worth $8,893,000 after acquiring an additional 424 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 1.0 %

NYSE UNH opened at $594.32 on Friday. The stock has a market cap of $548.81 billion, a PE ratio of 36.33, a P/E/G ratio of 1.64 and a beta of 0.58. The business has a 50 day moving average price of $569.08 and a two-hundred day moving average price of $517.57. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $607.94. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.14 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.41%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of a number of recent analyst reports. Royal Bank of Canada increased their price target on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Robert W. Baird raised their price target on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. TD Cowen increased their price objective on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Wells Fargo & Company upped their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.